本文へ移動
cccskills
無料GitHub で公開

es-cushing-follow-up-tests-comorbidities-low-ct-density-adrenal-adenoma

This skill suggests follow-up tests for specific comorbidities associated with Cushing's syndrome in patients with adrenal adenoma when CT density is less than 10 Hounsfield units. Use when managing a post-adrenalectomy Cushing's syndrome patient with confirmed adrenal adenoma pathology and low-density imaging (<10 HU).

インストール方法を見る

含まれるファイル(1)

  • SKILL.md3.0 KB

SKILL.md(原文)

インストールする前に、エージェントに与えられる指示の中身を確認できます。

Follow-Up Tests for Specific Comorbidities in Adrenal Adenoma Patients If CT Density Is Less Than 10 Hounsfield Units

STEP 1 — Gather Information

Confirm postoperative cortisol levels, verify adrenal adenoma pathology, obtain CT density measurement (Hounsfield units), and document baseline comorbidities (hypertension, diabetes, dyslipidemia, osteoporosis, psychiatric symptoms).
Action: Proceed to assess CT density threshold.

STEP 2 — Rule In / Rule Out

Is the adrenal adenoma CT density <10 HU?

  • Yes: Continue to comorbidity stratification.
  • No: Follow guideline recommendation to evaluate for malignancy using imaging (see Section 7.3).
    Decision: Branch to Step 3 if density <10 HU; otherwise pursue malignancy workup.

STEP 3 — Classify or Stratify

Stratify comorbidities into four domains: cardiovascular (blood pressure, lipid panel), metabolic (fasting glucose, HbA1c), bone (DEXA scan), and psychiatric (PHQ-9/GAD-7 screening).
Action: Order targeted screening panels for each domain based on stratification.

STEP 4 — Decide

For abnormal results: initiate condition-specific treatment per guidelines (e.g., antihypertensive for BP >130/80, glucose-lowering for HbA1c ≥5.7%, bone therapy for T-score ≤-2.5, psychiatry referral for PHQ-9 ≥10).
If all screens normal: schedule repeat comorbidity assessment annually or sooner if symptoms develop.
Decision: Treat abnormal findings or establish routine surveillance.

Clinical Guardrails / Mimics / Pitfalls

Do not assume comorbidity resolution after adrenalectomy; persistent subclinical hypercortisolism may mask ongoing risk. Avoid mistaking a low-density adenoma for carcinoma without further imaging when clinical suspicion exists. Do not delay screening due to perceived remission; comorbidities often progress silently. Never omit baseline vitamin D and calcium assessment before interpreting bone density.

Concrete Clinical Example

A 45‑year‑old woman status‑post left adrenalectomy for an 8 mm adrenal adenoma (CT density 7 HU) with prior Cushing’s syndrome; postoperative UFC normal. Screening reveals new‑onset hypertension (BP 148/92 mmHg) and prediabetes (HbA1c 5.9%). Initiated lisinopril 10 mg daily and lifestyle modification; repeat labs in 3 months.

Source: Treatment of Cushing’s Syndrome: An Endocrine Society Clinical Practice Guideline, Nieman et al., Endocrine Society, 2015, DOI:10.1210/jc.2015-1818

TODO: consider adding scripts/calc.py for the es-cushing-follow-up-tests-comorbidities-low-ct-density-adrenal-adenoma calculator

レビュー

まだレビューはありません。使ってみた感想をお寄せください。

同じリポジトリのスキル

概要と使いどころ

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

dromlakhani のスキルをすべて見る

このスキルの問題を報告する